CIK 0001714899
- Large accelerated filer
Denali Therapeutics Inc.
Sign in to watch- Ticker
- DNLI
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 463872213
- Phone
- +1 650-866-8547
- Business address
- 161 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA, 94080
- 8-K Event Results of operations
- 8-K Event Material agreement · Other events
- 8-K Event Results of operations · Other events
- 8-K Event Other events
- 8-K Event Results of operations
- 8-K Event Results of operations
- 8-K Event Shareholder vote results
- 8-K Event Results of operations
- 8-K Event Results of operations
- 8-K Event Other events
- 8-K Event Other events
- 8-K Event Results of operations · Executive or director change
- 8-K Event Material agreement · Regulation FD disclosure
- 8-K Event Results of operations
- 8-K Event Other events
- 8-K Event Shareholder vote results
- 8-K Event Material agreement · Acquisition or sale completed · Regulation FD disclosure
- 8-K Event Results of operations
- 8-K Event Material agreement · New debt or obligation
- 8-K Event Results of operations · Executive or director change
Page 5 of 6 · 102 filings